Avsar.

Healthcare · Pharmaceuticals

Aarti Pharmalabs Ltd (AARTIPHARM)

₹673.80

Mkt cap
₹6,513 Cr
P/E ratio
36.80
P/B
2.88
Div yield
0.70%
ROE
8.59%
ROCE
10.70%
EPS (TTM)
₹18.31
Book value
₹234
52W range
592–951
Sector
Healthcare

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals [1]

NSE AARTIPHARMBSE 543748www.aartipharmalabs.com
Health check
Cautious
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−29.17% from high
₹674
₹592+13.83% from low₹951
Current
₹673.80
Prev close
₹675.00
Day
−0.18%
Price performance
1D
−0.18%
1W
−3.46%
1M
−2.45%
3M
−2.76%
6M
−10.48%
1Y
−29.66%
YTD
−9.20%

Financials

F
Revenue, profit & margin
P/E ratio
36.8×
AARTIPHARM is 6% above the sector median of 34.9×
AARTIPHARM36.8×
Sector median34.9×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales485458440449506555458538564386418432583
Expenses405373352353388459364409418293344330470
Operating Profit8085889611896941291469374102113
OPM %16%19%20%21%23%17%20%24%26%24%18%24%19%
Other Income10112245-220214
Interest64445561077111317
Depreciation16171819192021232323252928
Profit before tax5964677496747210111565396382
Tax %27%26%23%29%32%25%24%26%23%24%28%24%25%
Net Profit43475253655555748850284861
EPS in Rs4.735.205.725.827.206.126.038.169.755.463.085.296.74
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Mar 2026
43.08%Promoter
Promoters43.08%0.02
FIIs8.39%0.70
DIIs7.40%0.26
Public41.10%0.44
Government0.01%
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,951.5037.684,68,2300.82%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹7,273.0073.611,93,0750.41%751+13.44%2,831+9.52%21.96%
Torrent Pharma.₹5,017.8077.491,69,8250.76%364−20.58%4,197+41.84%15.19%
Cipla₹1,438.0030.521,16,1680.90%543−54.61%6,541−2.80%15.49%
Zydus Lifesci.₹1,156.9021.271,15,4010.09%1,341+21.92%7,587+16.22%21.14%
Lupin₹2,493.0020.051,13,9880.72%1,469+101.49%7,475+31.89%29.93%
Mankind Pharma₹2,543.1052.281,05,0290.04%559+34.23%3,443+11.81%13.50%
Aarti Pharma₹718.2536.846,5130.70%61−30.81%583+3.35%10.70%
Median: 156 Co.₹434.6834.872,0060.08%12+22.43%177+16.46%15.19%

Filings

D
Annual reports3
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bse
Concall transcripts35
TranscriptJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTSep 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024RECAug 2024
Credit ratings6
Rating update 13 MarcrisilRating update 17 Jul 2025crisilRating update 17 Mar 2025crisilRating update 26 Jun 2024crisilRating update 8 May 2024crisilRating update 21 Feb 2023crisil
Announcements5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 JulAnnouncement under Regulation 30 (LODR)-Press Release / Media Release 30 Jun - Inaugurated Tarapur Unit 5 manufacturing block, adding 3,600 TPA Xanthine capacity to reach 9,600 TPA.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 24 JunClosure of Trading Window 24 JunAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript 1 Jun - Transcript of Q4 FY 26 Earnings Conference Call.